We Look Forward to Your Message
As one of the few legally approved stem cell clinics, we receive a high volume of inquiries. As a result, it may take some time for us to get back to you.
To help us respond as quickly and efficiently as possible, please fill out the form with as much detail as you can. We appreciate your patience and understanding.
Contraindications
Our stem cell treatments are experimental, but we only treat patients for whom we believe the risk/benefit ratio indicates treatment based on the state of the art, i.e., medical, scientific evidence.
Please understand that we therefore do not treat patients for whom the following points apply:
- Active cancer in the last two years
- Not yet of legal age
- Existing pregnancy or lactation period
- Unable to breathe on own, ventilator
- Difficulty breathing in supine position
- Dysphagia (extreme difficulty swallowing)
- Psychiatric disorder
- Active infectious disease (Hepatitis A, B, C, HIV, Syphilis, or other)
ANOVA IRM
Institute for Regenerative Medicine GmbH
Strahlenbergerstr. 110
63067 Offenbach am Main
Deutschland
T: +49 (0) 69 50 50 00 944
F: +49 (0) 69 50 50 00 955
If you need additional information about ANOVA, please feel free to give us a call or simply contact us by e-mail by using the form.
Our working hours:
Monday to Thursday
9:00am - 12:00pm
13:00am - 16:30pm
Friday
9:00am - 13:00pm
Saturday and Sunday our offices are closed.
About Anova
ANOVA Institute for Regenerative Medicine is a German private clinic that offers the most advanced stem-cell based treatments, including a full diagnostic work-up with state-of-the-art technologies.
At ANOVA we develop novel stem cell-based therapies and bring them from the laboratory setting to clinical practice. ANOVA's scientists and doctors have made it their primary goal to provide patients with priviledged access to urgently needed stem cell-based therapies for a variety of diseases.
We work strictly inside the respective national legal frameworks for the handling of stem cells, and have developed novel, safe and effective ways to make stem cell-based therapies available to patients in the heart of Europe.